Categories AlphaGraphs, Earnings, Health Care

Trxade (MEDS) delivers another quarter of strong revenue growth

Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales. The top-line was way ahead of the average Wall Street consensus of $3.01 million. 

Meanwhile, net income came in at $0.02 per share, a cent shy of the street consensus.

Trxade Group Q3 2020 earnings

CEO Suren Ajjarapu said in a statement, “The COVID-19 pandemic has only underscored the importance of an integrated platform like ours, which enables independent pharmacies to remain competitive and profitable in a changing drug procurement marketplace.”

MEDS stock shot up 34% during after-market hours on the stronger-than-expected revenues. The stock has declined 18% since the beginning of this year.

In the third quarter, the Tampa, Florida-based firm added 144 new independent pharmacies to its network. The company now has approximately 11,800 registered pharmacy members.

Trxade, which brings together independent pharmacies under one umbrella through its web-based purchasing platform, is present in all 50 states and is rapidly adding pharmacies to its network.

Prior performance

Most Popular

Oracle (ORCL) Q4 earnings, revenue beat Street view

Software giant Oracle Corporation (NYSE: ORCL) reported a 28% growth in fourth-quarter earnings, aided by an increase in revenues. The results also topped Wall Street's prediction. At $11.2 billion, revenues

Southwest Airlines (LUV): Three factors that work in favor of this airline stock

Shares of Southwest Airlines (NYSE: LUV) have gained 56% over the past 12 months and 22% since the beginning of this year. A key player in an industry that was

Lululemon’s growth story could continue in 2021

Lululemon Athletica (NASDAQ: LULU) had a very strong start to fiscal 2021. Apparently, the company is experiencing a stronger momentum in the year 2021, compared to 2019. The company surpassed

Add Comment
Viewing Highlight